Skip to content
10-Q

Quarterly Report

BIONOVATE TECHNOLOGIES CORP.

0001640334-20-001249

← back to feed
Filed
May 15, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2020 · May 7, 2020 59.42M sh
Current Liabilities Q3 2020 · Mar 31, 2020 $375.7K
Current Liabilities Q3 2020 · Jun 30, 2019 $332.29K
Total Liabilities Q3 2020 · Mar 31, 2020 $375.7K
Total Liabilities Q3 2020 · Jun 30, 2019 $332.29K
Eps Diluted Q3 2020 · Mar 31, 2020 $0.00
Eps Diluted Q3 2020 · Mar 31, 2020 −$0.01
Eps Diluted Q3 2020 · Mar 31, 2019 −$0.16
Eps Diluted Q3 2020 · Mar 31, 2019 −$1.03
Stockholders Equity Q3 2020 · Mar 31, 2019 −$300.6K
Stockholders Equity Q3 2020 · Dec 31, 2018 −$281.7K
Stockholders Equity Q3 2020 · Sep 30, 2018 −$251.67K
Stockholders Equity Q3 2020 · Jun 30, 2018 −$309.68K
Sga Expense Q3 2020 · Mar 31, 2019 $875
Sga Expense Q3 2020 · Mar 31, 2019 $5.81K
Net Income Q3 2020 · Mar 31, 2019 −$160.17K
Operating Income Q3 2020 · Mar 31, 2019 −$5.39K
Operating Income Q3 2020 · Mar 31, 2019 −$38.83K